ライフサイエンスコーパス: islet cell transplantation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ed inflammatory loss of graft function after islet cell transplantation.

2 ed its efficacy in a rhesus macaque model of islet cell transplantation.

3 study islet cells in the rat pancreas and in islet cell transplantation.

4 ing of allograft injury in humans undergoing islet cell transplantation.

5 CXCR4-CXL12 axis, to promote engraftment of islet cell transplantation.

6 s significant therapeutic potential in human islet cell transplantation.

7 ll loss is a significant problem in clinical islet cell transplantation.

8 -2 diabetes, and also reduces the success of islet cell transplantation.

9 diabetic rats was reversed by captopril and islet cell transplantation.

10 a means to alleviate limitations surrounding islet cell transplantation.

11 may have practical applications in clinical islet cell transplantation.

12 ting potential treatments for IDDM including islet cell transplantation.

13 oon retrograde transvenous obliteration, and islet cell transplantation.

14 ti-CD154 a unique agent for further study in islet cell transplantation.

15 the consequences of targeting CD45 in murine islet cell transplantation.

16 cular events that might positively influence islet cell transplantation.

17 red a risk factor for liver, intestinal, and islet cell transplantation.

18 e loss of functional islets after allogeneic islet cell transplantation.

19 Efforts toward routine islet cell transplantation as a means for reversing type

20 The promise of islet cell transplantation cannot be fully realized in t

21 rectly applicable to ongoing improvements in islet cell transplantation for human diabetes, particula

22 Increasing evidence suggests that islet cell transplantation for patients with type I diab

23 ent in the clinical relevance of intraportal islet cell transplantation for treatment of type 1 diabe

24 cess of sirolimus and low-dose tacrolimus in islet cell transplantation has influenced many transplan

25 Islet cell transplantation has limited effectiveness bec

26 Clinical islet cell transplantation has resulted in insulin indep

27 d diabetic, and diabetic groups treated with islet cell transplantation (ICT), protein kinase C (PKC)

28 port the results of the first pilot trial of islet cell transplantation (ICTx) in patients with diabe

29 analysis plans for future pivotal trials of islet cell transplantation in type 1 diabetes.

30 n as the Edmonton protocol demonstrates that islet cell transplantation is becoming a therapeutic rea

31 Although islet cell transplantation is considered an ideal form o

32 The optimal site for pancreatic islet cell transplantation is presently unclear, althoug

33 blood mononuclear cells into R- mice before islet cell transplantation leads to acute cellular rejec

34 nts with type 1 diabetes of longer duration, islet cell transplantation may be more effective than me

35 Islet cell transplantation resulted in normoglycemia wit

36 vs placebo (RR 0.60; 95% CI 0.41-0.86), and islet cell transplantation vs medical therapy (RR 0.25;

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。